Skip to content

ENTEROLOGICS, INC.: 10-Q filed 2011-11-23

What ENTEROLOGICS, INC. reported in its quarterly report filed 2011-11-23 (fiscal Q3 2011): 23 published measures, 74 facts as tagged in accession 0001477932-11-002672.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-23
Fiscal period
fiscal Q3 2011
Accession
0001477932-11-002672 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ENTEROLOGICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-30610,868USD
At 2010-12-312,858USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-30180,396USD
At 2010-12-3123,378USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-30430,472USD
At 2010-12-31-20,520USD
At 2009-12-3140,011USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-69,368USD92
2011-01-01 to 2011-09-30-155,008USD273
2009-09-02 to 2011-09-30-235,718USD759
2010-01-01 to 2010-12-31-72,611USD365
2010-07-01 to 2010-09-30-11,439USD92
2010-01-01 to 2010-09-30-56,369USD273
2009-09-02 to 2009-12-31-8,099USD121

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-128,663USD273
2009-09-02 to 2011-09-30-186,735USD759
2010-01-01 to 2010-09-30-43,467USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-30463,000USD273
2009-09-02 to 2011-09-30523,130USD759
2010-01-01 to 2010-09-301,520USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30302,145USD273
2009-09-02 to 2011-09-30303,145USD759
2010-01-01 to 2010-09-301,000USD273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-09-306,000USD273
2009-09-02 to 2011-09-3018,000USD759
2010-07-01 to 2010-09-303,000USD92
2010-01-01 to 2010-09-309,000USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-3033,250USD
At 2010-12-311,858USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-07-01 to 2011-09-30489USD92
2011-01-01 to 2011-09-30790USD273
2009-09-02 to 2011-09-301,091USD759
2010-07-01 to 2010-09-3030USD92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-30113,729USD
At 2010-12-3123,378USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-3028,531USD
At 2010-12-319,107USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-09-30481,353USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2011-09-30564USD
At 2010-12-311,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-07-01 to 2011-09-3059,697USD92
2011-01-01 to 2011-09-30129,218USD273
2009-09-02 to 2011-09-30209,632USD759
2010-07-01 to 2010-09-3011,409USD92
2010-01-01 to 2010-09-3056,328USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2011-09-3031,004USD92
2011-01-01 to 2011-09-3043,917USD273
2009-09-02 to 2011-09-3043,917USD759
2010-07-01 to 2010-09-300USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3026,020,000shares
At 2010-12-3126,020,000shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-30764USD
At 2010-12-31148USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-59,697USD92
2011-01-01 to 2011-09-30-129,218USD273
2009-09-02 to 2011-09-30-209,632USD759
2010-07-01 to 2010-09-30-11,409USD92
2010-01-01 to 2010-09-30-56,328USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-3019,631USD92
2011-01-01 to 2011-09-3036,678USD273
2009-09-02 to 2011-09-3061,954USD759
2010-07-01 to 2010-09-303,551USD92
2010-01-01 to 2010-09-3020,638USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-69,368USD92
2011-01-01 to 2011-09-30-155,008USD273
2009-09-02 to 2011-09-30-235,718USD759
2010-07-01 to 2010-09-30-11,439USD92
2010-01-01 to 2010-09-30-56,369USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-09-30425,000USD273
2009-09-02 to 2011-09-30473,130USD759
2010-01-01 to 2010-09-3020USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-7,695USD273
2009-09-02 to 2011-09-303,534USD759
2010-01-01 to 2010-09-305,247USD273

Inspect the source

Entity
ENTEROLOGICS, INC. / CIK 0001483731
Captured
SEC response SHA-256
ceb1473be0412d652915b8c039ba0f981e77a820700a20eecefa254e109805c3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001483731.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))